- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Bakersfield, California, United States
Clinical trial condition
Infection, Human Immunodeficiency Virus
Explore clinical trials studying Infection, Human Immunodeficiency Virus. Study availability and eligibility vary by location and protocol.
107 public trials
2 recruiting studies
Infection, Human Immunodeficiency Virus trial results
NCT01803074
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Berlin, Germany
Completed
GSK1349572 Hepatic Impairment Study
NCT01231529
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States
Completed
Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)
NCT02741557
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT01068925
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
NCT03078556
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT03314064
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Kazan', Russia
- GSK Investigational Site Kemerovo, Russia
- GSK Investigational Site Krasnodar, Russia
- GSK Investigational Site Moscow, Russia
NCT00945282
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Buenos Aires, Argentina
NCT01384734
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Coral Gables, Florida, United States
NCT02076386
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Freiburg im Breisgau, Baden-Wurttemberg, Germany
- GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Stuttgart, Baden-Wurttemberg, Germany
- GSK Investigational Site Tübingen, Baden-Wurttemberg, Germany